IL42016A - History of dopamine and their preparation - Google Patents

History of dopamine and their preparation

Info

Publication number
IL42016A
IL42016A IL42016A IL4201673A IL42016A IL 42016 A IL42016 A IL 42016A IL 42016 A IL42016 A IL 42016A IL 4201673 A IL4201673 A IL 4201673A IL 42016 A IL42016 A IL 42016A
Authority
IL
Israel
Prior art keywords
methyl
hydrogen
phenethylamine
methoxylated
propyl7
Prior art date
Application number
IL42016A
Other languages
English (en)
Hebrew (he)
Other versions
IL42016A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22918877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL42016(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL42016A0 publication Critical patent/IL42016A0/xx
Publication of IL42016A publication Critical patent/IL42016A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL42016A 1972-04-12 1973-04-12 History of dopamine and their preparation IL42016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24346672A 1972-04-12 1972-04-12

Publications (2)

Publication Number Publication Date
IL42016A0 IL42016A0 (en) 1973-06-29
IL42016A true IL42016A (en) 1976-05-31

Family

ID=22918877

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42016A IL42016A (en) 1972-04-12 1973-04-12 History of dopamine and their preparation

Country Status (31)

Country Link
JP (2) JPS5825656B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR790000113B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR203822A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT323719B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU472734B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE798051A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG23001A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1018188A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH569691A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (2) CS190448B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY963A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD107670B3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2317710C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK142750C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES413639A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2182947B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1392674A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK50178A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (2) HU166213B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE37511B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL42016A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KE (1) KE2870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY7800381A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL174459C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH11041A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (2) PL94207B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RO (2) RO65105A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE399064B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU496719A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
YU (2) YU36483B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA732136B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH585693A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-02-08 1977-03-15 Ciba Geigy Ag
US4342692A (en) * 1980-10-20 1982-08-03 Usv Pharmaceutical Corporation Pyrrolidines
FI822585A7 (fi) * 1981-07-22 1983-01-23 Syntex Inc Sydän-verisuonisysteemiä säätäviä ja antihypertensiivisiä substituoituja pyrrolidiineja.
JPS6061523A (ja) * 1983-09-16 1985-04-09 Shionogi & Co Ltd 経口用ドブタミン製剤
IL85438A0 (en) * 1987-02-24 1988-07-31 Lilly Co Eli Improvements in or relating to dobutamine salts
JPH0383364U (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1989-12-18 1991-08-23
AU658188B2 (en) * 1991-05-20 1995-04-06 Tsumura & Co. Phellodendrine analogs and allergy type IV suppressor containing the same as active ingredient
ATE155125T1 (de) * 1993-04-13 1997-07-15 Duphar Int Res Herstellung von dobutamin verbindungen
EP0620208B1 (en) * 1993-04-13 1997-07-09 Duphar International Research B.V Production of dobutamine compounds
PT1546088E (pt) 2002-10-03 2015-03-16 Novaremed Ltd Compostos para utilização no tratamento de doenças auto-imunes, de doenças imuno-alérgicas e de rejeição de órgãos ou tecidos transplantados
US7674829B2 (en) 2004-03-26 2010-03-09 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
GB0804213D0 (en) 2008-03-06 2008-04-16 New Era Biotech Ltd A method of printing or preventing pain
ES2547730T3 (es) 2009-07-31 2015-10-08 Cognition Therapeutics, Inc. Inhibidores del deterioro cognitivo
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
CA2846604A1 (en) * 2011-08-25 2013-02-28 Cognition Therapeutics, Inc. Compositions and methods for treating neurodegenerative disease
JP6517827B2 (ja) 2014-01-31 2019-05-22 コグニション セラピューティクス,インコーポレイテッド イソインドリン組成物および神経変性疾患の治療方法
CN110869011B (zh) 2017-05-15 2024-01-05 考格尼申治疗股份有限公司 用于治疗神经退行性疾病的组合物
CN114524734B (zh) * 2021-12-27 2024-04-26 嘉实(湖南)医药科技有限公司 一种盐酸多巴酚丁胺的制备方法
CN117326958B (zh) * 2023-09-21 2025-07-11 锦州奥鸿药业有限责任公司 一种高纯度盐酸多巴酚丁胺的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2276619A (en) * 1942-03-17 N-phentlaliphatic-dihtoroxyphentnl

Also Published As

Publication number Publication date
BE798051A (fr) 1973-10-11
DD107670A5 (de) 1974-08-12
ZA732136B (en) 1974-03-27
YU321279A (en) 1983-04-27
JPS497237A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-01-22
HU166213B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-02-28
YU37113B (en) 1984-08-31
RO65105A (ro) 1980-01-15
AT323719B (de) 1975-07-25
SE399064B (sv) 1978-01-30
PL90695B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-01-31
AR203822A1 (es) 1975-10-31
CH569691A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-28
JPS58131945A (ja) 1983-08-06
FR2182947A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-12-14
DD107670B3 (de) 1988-04-06
JPS5825656B2 (ja) 1983-05-28
CY963A (en) 1978-12-22
HU167597B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-28
KE2870A (en) 1978-09-01
CA1018188A (en) 1977-09-27
DK142750B (da) 1981-01-12
AU472734B2 (en) 1976-06-03
YU97673A (en) 1982-02-25
CS190406B2 (en) 1979-05-31
YU36483B (en) 1984-02-29
BG23001A3 (bg) 1977-05-20
NL7305097A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-10-16
IL42016A0 (en) 1973-06-29
DK142750C (da) 1981-08-17
RO70892A (ro) 1982-02-26
HK50178A (en) 1978-09-15
MY7800381A (en) 1978-12-31
JPS6221343B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-05-12
PL94207B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-07-30
IE37511B1 (en) 1977-08-03
CH580563A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-10-15
DE2317710C2 (de) 1983-08-04
ES413639A1 (es) 1976-01-16
SU496719A3 (ru) 1975-12-25
DE2317710A1 (de) 1973-10-18
GB1392674A (en) 1975-04-30
AU5438573A (en) 1974-10-17
KR790000113B1 (en) 1979-03-20
NL174459B (nl) 1984-01-16
CS190448B2 (en) 1979-05-31
FR2182947B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-07-02
PH11041A (en) 1977-10-25
NL174459C (nl) 1984-06-18

Similar Documents

Publication Publication Date Title
IL42016A (en) History of dopamine and their preparation
US7205425B2 (en) Optically active nitro alcohol derivatives, optically active amino alcohol derivatives, and process for producing thereof
KR100446893B1 (ko) Cns 장해 치료용 모노아민 재흡수 억제제
USRE37355E1 (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients
US4868344A (en) Novel process of producing phenyl or substituted phenylalkylamine pharmaceutical agents and novel chiral intermediates of high enantiomeric purity useful therein
AU702776B2 (en) Use of aryl-substituted cyclobutylalkylamines for treating obesity
EP2285770B1 (en) Process for the synthesis of arformoterol
US3987200A (en) Method for increasing cardiac contractility
WO2008035358A2 (en) Process for preparing dapoxetine
IE894118L (en) An impoved process for the preparation of a valuable drug
CA1061357A (en) Phenylalkylamines
EP4401725A1 (en) Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric salts
CN102951980A (zh) 一种亚胺不对称催化加氢的方法
CA1171086A (en) Substituted 2-phenyl-ethylamines and isosteric compounds, process for their production and use
NZ535548A (en) Manufacture of phenyl ethylamine compounds, in particular venlafaxine
US4028415A (en) Diphenylpropylamines
US3047628A (en) Benzylamine derivatives
CN111777520B (zh) 多位取代的二甲氨基苯基乙酸类化合物的合成方法
Zhang et al. Ga (OTf) 3‐catalyzed Three‐component Mannich Reaction in Water Promoted by Ultrasound Irradiation
CN107501136A (zh) 一种制备偕二芳基甲胺类化合物的方法
US4918246A (en) Process for preparing optically active haloalcohols
CN101679210B (zh) 旋光性α氨基乙缩醛外消旋化的方法
Cruz et al. Ephedrines and their acyclic derivatives
Su et al. An Efficient Ceric Ammonium Nitrate‐Catalyzed Aromatic Amination of (Ferrocenyl)(phenyl) methanol
JPH0428253B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)